---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-005458"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2026-07-10T20:54:05+00:00"
generated_at: "2026-07-10T20:55:04.631390+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma settles dispute with former Nora Pharma president for CAD$1.5M

## Summary
- Company to pay CAD$1.5M (approx US$1.06M) to Malek Chamoun to settle all claims and cross-claims.
- Settlement includes earn-out, bonuses, indemnity in lieu of notice, and expense reimbursement; no admission of liability.
- Chamoun must sell all his Sunshine Biopharma shares within 30 days; non-compete and non-solicitation obligations terminated.
- Mutual releases of all claims; parties agree to confidentiality and non-disparagement.

## SEC filing metadata
- accession: 0001683168-26-005458
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2026-07-10T20:54:05+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/0001683168-26-005458-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316826005458/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-005458
- JSON: https://secwatch.observer/filing/0001683168-26-005458.json
- Plain text: https://secwatch.observer/filing/0001683168-26-005458.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.